Sign inJoin waitlistJoin the waitlist

Amol Ghia

Professor, Radiation Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Radiation Oncology
University of Utah School of Medicine
2008–2012
University of Wisconsin School of Medicine and Public Health
2004–2006
University of Colorado School of Medicine
2000–2004

Research

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
The Lancet Oncology · 2017 · 624 citations
Nuclear EGFR contributes to acquired resistance to cetuximab
Oncogene · 2009 · 254 citations
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial
JAMA Oncology · 2023 · 191 citations

Claudio Tatsui
52 papers
Laurence Rhines
50 papers
Paul Brown
46 papers
Behrang Amini
38 papers
Mary McAleer
38 papers
Debra Yeboa
36 papers
Andrew Bishop
30 papers · 8 as a resident
Thomas Beckham
26 papers
Chenyang Wang
25 papers · 1 as a resident
Susan McGovern
22 papers
Caroline Chung
18 papers
EC
Eric Chang
17 papers

Clinical trials

Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2024–2029
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
Principal investigator · Active not recruiting
M.D. Anderson Cancer Center
2018–2026
Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2017–2028
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2015–2026